Serostim
Chronic Liver Failure
Post Graduate Institute of Medical Education and Research, Chandigarhprotein_peptidePhase 2/3Active
B
60/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 46/ 100
- Competitive Position
- 89/ 100
Competitive context
4 Active assets in the Chronic Liver Failure cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Noradrenaline University of California, Los Angeles | Phase 4 | BB |
Angiotensin Ii University of California, Los Angeles | Phase 4 | BB |
Ribavirin Gilead Sciences | Phase 2 | B |
Sofosbuvir Gilead Sciences | Phase 2 | B |
rtx001 Resolution Therapeutics Limited | Phase 1/2 | CCC |
View all 10 →
Same molecule, other indications
Serostim is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →